Protagonist Therapeutics, Inc. (PTGX): Price and Financial Metrics
PTGX Price/Volume Stats
| Current price | $46.88 | 52-week high | $60.60 |
| Prev. close | $48.36 | 52-week low | $24.22 |
| Day low | $46.54 | Volume | 1,095,200 |
| Day high | $48.68 | Avg. volume | 982,287 |
| 50-day MA | $42.93 | Dividend yield | N/A |
| 200-day MA | $41.48 | Market Cap | 2.88B |
PTGX Stock Price Chart Interactive Chart >
Protagonist Therapeutics, Inc. (PTGX) Company Bio
Protagonist Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing peptide-based new chemical entities to address significant unmet medical needs. The company was founded in 2006 and is based in Milpitas, California.
PTGX Price Returns
| 1-mo | 24.71% |
| 3-mo | N/A |
| 6-mo | 5.73% |
| 1-year | 65.77% |
| 3-year | 93.88% |
| 5-year | 650.08% |
| YTD | 21.45% |
| 2024 | 68.34% |
| 2023 | 110.17% |
| 2022 | -68.10% |
| 2021 | 69.64% |
| 2020 | 185.96% |
Loading social stream, please wait...